CALCULATION OF REGISTRATION FEE
Title of Each Class of Securities Offered
|
|
Maximum Aggregate Offering Price
|
|
Amount of Registration Fee
|
Enhanced Buffered Jump Securities due 2021
|
|
$250,000
|
|
$32.45
|
|
|
|
|
|
June 2020
Pricing Supplement No. 4,293
Registration Statement Nos.
333-221595; 333-221595-01
Dated June 30, 2020
Filed pursuant to Rule 424(b)(2)
Morgan
Stanley Finance LLC
Structured
Investments
Opportunities in U.S. Equities
Enhanced Buffered Jump Securities Based on the
Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5,
2021
Fully and Unconditionally Guaranteed by Morgan
Stanley
Principal at Risk Securities
The Enhanced Buffered Jump Securities, which we refer to as the
securities, are unsecured obligations of Morgan Stanley Finance LLC (“MSFL”) and are fully and unconditionally guaranteed
by Morgan Stanley. The securities have the terms described in the accompanying product supplement for Jump Securities,
index supplement and prospectus, as supplemented and modified by this document. The securities pay no interest and will
instead pay an amount in cash at maturity that may be greater than or less than the stated principal amount, depending on the closing
values of the underlying indices on the valuation date. If the final index value of each underlying index
is greater than or equal to 90% of its respective initial index value, which we refer to as the respective downside threshold
value, you will receive the stated principal amount for each security that you hold at maturity plus the upside payment of $105.00
per security. However, if the final index value of either underlying index is less than its respective
downside threshold value, you will be exposed to the decline in the level of the worst performing underlying index beyond the buffer
amount of 10%, and you will lose some or a significant portion of your initial investment. The payment at maturity
may be significantly less than the stated principal amount, and you could lose up to 90% of your investment. Because
the payment at maturity on the securities is based on the worst performing of the underlying indices, a decline in either final
index value below 90% of its respective initial index value will result in a loss on your investment, even if the other underlying
index has appreciated or has not declined as much. The securities are for investors who seek an equity index-based return and who
are willing to risk their principal, risk exposure to the worst performing of two underlying indices and forgo current income and
returns above the fixed upside payment in exchange for the upside payment and buffer features that in each case apply to a limited
range of performance of the worst performing underlying index. The securities are notes issued as part of MSFL’s
Series A Global Medium-Term Notes Program.
All payments are subject to our credit risk. If
we default on our obligations, you could lose some or all of your investment. These securities are not secured obligations
and you will not have any security interest in, or otherwise have any access to, any underlying reference asset or assets.
FINAL TERMS
|
Issuer:
|
Morgan Stanley Finance LLC
|
Guarantor:
|
Morgan Stanley
|
Issue price:
|
$1,000 per security
|
Stated principal amount:
|
$1,000 per security
|
Pricing date:
|
June 30, 2020
|
Original issue date:
|
July 6, 2020 (4 business days after the pricing date)
|
Maturity date:
|
October 5, 2021
|
Aggregate principal amount:
|
$250,000
|
Interest:
|
None
|
Underlying indices:
|
The S&P 500® Index (the “SPX Index”) and the NASDAQ-100 Index® (the “NDX Index”)
|
Payment at maturity:
|
·
If the final index value of each underlying
index is greater than or equal to its respective downside threshold value:
$1,000 + the upside payment
·
If the final index value of either underlying
index is less than its respective downside threshold value, meaning the value of either underlying index has declined
by more than the buffer amount of 10% from its respective initial index value to its respective final index value:
$1,000 + $[1,000 × (index percent change of
the worst performing underlying index + 10%)]
Because the index percent change of the worst performing
underlying index will be less than -10% in this scenario, the payment at maturity will be less, and potentially significantly less,
than the stated principal amount of $1,000.
|
Upside payment:
|
$105.00 per security (10.50% of the stated principal amount)
|
Index percent change:
|
With respect to each underlying index, (final index value - initial index value) / initial index value
|
Worst performing underlying index:
|
The underlying index that has declined the most, meaning that it has the lesser index percent change
|
Initial index value:
|
With respect to the SPX Index, 3,100.29, which is the index closing
value of such index on the pricing date
With respect to the NDX Index, 10,156.850, which is the index
closing value of such index on the pricing date
|
Downside threshold value:
|
With respect to the SPX Index, 2,790.261, which is 90% of the
initial index value for such index
With respect to the NDX Index, 9,141.165, which is 90% of the
initial index value for such index
|
Final index value:
|
With respect to each underlying index, the index closing value of such index on the valuation date
|
Valuation date:
|
September 30, 2021, subject to postponement for non-index business days and certain market disruption events
|
Buffer amount:
|
10%
|
Minimum payment at maturity:
|
$100 per security
|
CUSIP / ISIN:
|
61771BLS1 / US61771BLS15
|
Listing:
|
The securities will not be listed on any securities exchange.
|
Agent:
|
Morgan Stanley & Co. LLC (“MS & Co.”), an affiliate of MSFL and a wholly owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.”
|
Estimated value on the pricing date:
|
$962.20 per security. See “Investment Summary” on page 2.
|
Commissions and issue price:
|
Price to public(1)
|
Agent’s commissions and fees(2)
|
Proceeds to us(3)
|
Per security
|
$1,000
|
$0
|
$1,000
|
Total
|
$250,000
|
$0
|
$250,000
|
(1) The securities will be sold only to investors purchasing
the securities in fee-based advisory accounts.
(2) MS & Co. expects to sell all of the securities that
it purchases from us to an unaffiliated dealer at a price of $1,000 per security, for further sale to certain fee-based advisory
accounts at the price to public of $1,000 per security. MS & Co. will not receive a sales commission with respect to the securities. See
“Supplemental information regarding plan of distribution; conflicts of interest.” For additional information,
see “Plan of Distribution (Conflicts of Interest)” in the accompanying product supplement for Jump Securities.
(3) See “Use of proceeds and hedging” on page
18.
The securities involve risks not associated with an investment
in ordinary debt securities. See “Risk Factors” beginning on page 7.
The Securities and Exchange Commission and state securities
regulators have not approved or disapproved these securities, or determined if this document or the accompanying product supplement,
index supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
The securities are not deposits or savings accounts and are
not insured by the Federal Deposit Insurance Corporation or any other governmental agency or instrumentality, nor are they obligations
of, or guaranteed by, a bank.
You should read this document together with the related product
supplement, index supplement and prospectus, each of which can be accessed via the hyperlinks below. Please also see
“Additional Terms of the Securities” and “Additional Information About the Securities” at the end of this
document.
References to “we,” “us” and “our”
refer to Morgan Stanley or MSFL, or Morgan Stanley and MSFL collectively, as the context requires.
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
Investment Summary
Principal at Risk Securities
The Enhanced Buffered Jump Securities Based on the Value of the
Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021 (the “securities”)
can be used:
|
§
|
As an alternative to direct exposure to the underlying
indices that provides a fixed return of 10.50% if the final index value of each underlying index is greater than or equal
to its respective downside threshold value;
|
|
§
|
To enhance returns and potentially outperform the
worst performing of the S&P 500® Index and the NASDAQ-100 Index® in a moderately bullish or moderately
bearish scenario; and
|
|
§
|
To obtain a buffer against a specified level of negative
performance in the worst performing underlying index.
|
The securities are exposed on a 1-to-1 basis to the percentage
decline of the final index value of the worst performing underlying index from its respective initial index value beyond the buffer
amount of 10%. Accordingly, 90% of your principal is at risk.
Maturity:
|
Approximately 1.25 years
|
Upside payment:
|
$105.00 per security (10.50% of the stated principal amount), payable only if the final index value of each underlying index is greater than or equal to its respective downside threshold value.
|
Buffer amount:
|
10%
|
Minimum payment at maturity:
|
$100 per security. You could lose up to 90% of the stated principal amount of the securities.
|
Interest:
|
None
|
The original issue price of each security is $1,000. This
price includes costs associated with issuing, selling, structuring and hedging the securities, which are borne by you, and, consequently,
the estimated value of the securities on the pricing date is less than $1,000. We estimate that the value of each security
on the pricing date is $962.20.
What goes into the estimated value on the pricing date?
In valuing the securities on the pricing date, we take into account
that the securities comprise both a debt component and a performance-based component linked to the underlying indices. The
estimated value of the securities is determined using our own pricing and valuation models, market inputs and assumptions relating
to the underlying indices, instruments based on the underlying indices, volatility and other factors including current and expected
interest rates, as well as an interest rate related to our secondary market credit spread, which is the implied interest rate at
which our conventional fixed rate debt trades in the secondary market.
What determines the economic terms of the securities?
In determining the economic terms of the securities, including
the upside payment, the buffer amount and the downside threshold values, we use an internal funding rate, which is likely to be
lower than our secondary market credit spreads and therefore advantageous to us. If the issuing, selling, structuring
and hedging costs borne by you were lower or if the internal funding rate were higher, one or more of the economic terms of the
securities would be more favorable to you.
What is the relationship between the estimated value on the
pricing date and the secondary market price of the securities?
The price at which MS & Co. purchases the securities in the
secondary market, absent changes in market conditions, including those related to the underlying indices, may vary from, and be
lower than, the estimated value on the pricing date, because the secondary market price takes into account our secondary market
credit spread as well as the bid-offer spread that MS & Co. would charge in a secondary market transaction of this type and
other factors. However,
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
because the costs associated with issuing, selling, structuring
and hedging the securities are not fully deducted upon issuance, for a period of up to 6 months following the issue date, to the
extent that MS & Co. may buy or sell the securities in the secondary market, absent changes in market conditions, including
those related to the underlying indices, and to our secondary market credit spreads, it would do so based on values higher than
the estimated value. We expect that those higher values will also be reflected in your brokerage account statements.
MS & Co. may, but is not obligated to, make a market in the
securities, and, if it once chooses to make a market, may cease doing so at any time.
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
Key Investment Rationale
The securities provide a return based on the performance of the
worst performing of the S&P 500® Index and the NASDAQ-100 Index®. If the final index
value of each underlying index, as determined on the valuation date, is greater than or equal to its respective downside threshold
value, you will receive the stated principal amount for each security that you hold at maturity plus the upside payment of $105.00
per security. However, if the final index value of either underlying index is less than its respective downside threshold
value, the payment due at maturity will be less, and possibly significantly less, than the stated principal amount of the securities. You
could lose up to 90% of the stated principal amount of the securities.
Upside Scenario
|
If the final index value of each underlying index is greater than or equal to its respective downside threshold value, the payment at maturity for each security will be equal to $1,000 plus the upside payment of $105.00.
|
Downside Scenario
|
If the final index value of either underlying index
is less than its respective downside threshold value, you will lose 1% for every 1% decline in the value of the worst
performing underlying index from its initial index value beyond the buffer amount of 10% (e.g., a 50% depreciation in the worst
performing underlying index from the respective initial index value to the respective final index value will result in a payment
at maturity of $600 per security).
Because the payment at maturity of the securities is based on
the worst performing of the underlying indices, a decline in either underlying index below its respective downside threshold value
will result in a loss on your investment, even if the other underlying index has appreciated or has not declined as much. You
could lose up to 90% of your investment.
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
Hypothetical Examples
The following hypothetical examples illustrate how to calculate
the payment at maturity on the securities. The following examples are for illustrative purposes only. The payment at
maturity on the securities is subject to our credit risk. The below examples are based on the following terms. The actual
initial index values and downside threshold values are set forth on the cover of this document.
Stated Principal Amount:
|
$1,000 per security
|
Hypothetical Initial Index Value:
|
With respect to the SPX Index: 2,200
With respect to the NDX Index: 9,000
|
Hypothetical Downside Threshold Value:
|
With respect to the SPX Index: 1,980, which is 90% of its hypothetical
initial index value
With respect to the NDX Index: 8,100, which is 90% of its hypothetical
initial index value
|
Upside Payment:
|
$105.00 (10.50% of the stated principal amount)
|
Buffer Amount:
|
10%
|
Minimum Payment at Maturity:
|
$100 per security
|
Interest:
|
None
|
EXAMPLE 1: Both underlying indices appreciate substantially,
and investors therefore receive the stated principal amount plus the upside payment.
Final index value
|
|
SPX Index: 3,960
|
|
|
NDX Index: 17,100
|
Index percent change
|
|
SPX Index: (3,960 – 2,200) / 2,200 = 80%
NDX Index: (17,100 – 9,000) / 9,000 = 90%
|
Payment at maturity
|
=
|
$1,000 + upside payment
|
|
=
|
$1,000 + $105.00
|
|
=
|
$1,105.00
|
|
|
|
In example 1, the final index value for the SPX Index has increased
from its initial index value by 80%, and the final index value for the NDX Index has increased from its initial index value by
90%. Because the final index value of each underlying index is above its respective downside threshold value, investors
receive at maturity the stated principal amount plus the upside payment of $105.00. Investors receive $1,105.00
per security at maturity and do not participate in the appreciation of either underlying index. Although both underlying
indices have appreciated substantially, the return on the securities is limited to the fixed upside payment of $105.00.
EXAMPLE 2: The final index values of both underlying
indices are at or above their respective downside threshold values, and investors therefore receive the stated principal amount
plus the upside payment.
Final index value
|
|
SPX Index: 2,090
|
|
|
NDX Index: 8,460
|
Index percent change
|
|
SPX Index: (2,090 – 2,200) / 2,200 = -5%
NDX Index: (8,460 – 9,000) / 9,000 = -6%
|
Payment at maturity
|
=
|
$1,000 + upside payment
|
|
=
|
$1,000 + $105.00
|
|
=
|
$1,105.00
|
|
|
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
In example 2, the final index value for the SPX Index has decreased
from its initial index value by 5%, and the final index value for the NDX Index has decreased from its initial index value by 6%. Because
the final index value of each underlying index is above its respective downside threshold value, investors receive at maturity
the stated principal amount plus the fixed upside payment of $105.00. Although both underlying indices have depreciated,
investors receive $1,105.00 per security at maturity.
EXAMPLE 3: The final index value of one of the underlying
indices is less than its respective downside threshold value. Investors are therefore exposed to the negative performance of the
worst performing underlying index, and lose 1% for every 1% decline beyond the buffer amount of 10%.
Final index value
|
|
SPX Index: 2,640
|
|
|
NDX Index: 6,300
|
Index percent change
|
|
SPX Index: (2,640 – 2,200) / 2,200 = 20%
NDX Index: (6,300 – 9,000) / 9,000 = -30%
|
Payment at maturity
|
=
|
$1,000 + [$1,000 × (index percent change of the worst performing underlying index + 10%)]
|
|
=
|
$1,000 + [$1,000 × (-30% + 10%)]
|
|
=
|
$800
|
|
|
|
In example 3, the final index value for the SPX Index has increased
from its initial index value by 20%, and the final index value for the NDX Index has decreased from its initial index value by
30%. Because one of the underlying indices has declined below its respective downside threshold value, investors do
not receive the upside payment and are exposed to the negative performance of the NDX Index, which is the worst performing underlying
index in this example. Under these circumstances, investors lose 1% for every 1% decline in the value of the worst performing
underlying index beyond the buffer amount of 10%. In this example, investors receive a payment at maturity equal to
$800 per security, resulting in a loss of 20%.
EXAMPLE 4: The final index values of both underlying
indices are less than their respective downside threshold values. Investors are therefore exposed to the negative performance of
the worst performing underlying index, and will lose 1% for every 1% decline beyond the buffer amount of 10%.
Final index value
|
|
SPX Index: 440
|
|
|
NDX Index: 3,600
|
Index percent change
|
|
SPX Index: (440 – 2,200) / 2,200 = -80%
NDX Index: (3,600 – 9,000) / 9,000 = -60%
|
Payment at maturity
|
=
|
$1,000 + [$1,000 × (index percent change of the worst performing underlying index + 10%)]
|
|
=
|
$1,000 + [$1,000 × (-80% + 10%)]
|
|
=
|
$300
|
|
|
|
In example 4, the final index value for the SPX Index has decreased
from its initial index value by 80%, and the final index value for the NDX Index has decreased from its initial index value by
60%. Because one or more underlying indices have declined below their respective downside threshold values, investors
do not receive the upside payment and are exposed to the negative performance of the SPX Index, which is the worst performing underlying
index in this example. Under these circumstances, investors lose 1% for every 1% decline in the value of the worst performing
underlying index beyond the buffer amount of 10%. In this example, investors receive a payment at maturity equal to $300 per security,
resulting in a loss of 70%.
Because the payment at maturity of the securities is based
on the worst performing of the underlying indices, a decline in the final index value of either underlying index to below its respective
downside threshold value will result in a loss of some or a significant portion of your investment, even if the other underlying
index has appreciated or has not declined as much. You could lose up to 90% of your investment in the securities.
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
Risk Factors
The following is a non-exhaustive list of certain key risk
factors for investors in the securities. For further discussion of these and other risks, you should read the section
entitled “Risk Factors” in the accompanying product supplement, index supplement and prospectus. You should
also consult with your investment, legal, tax, accounting and other advisers in connection with your investment in the securities.
|
§
|
The securities do not pay interest and provide
for the minimum payment at maturity of only 10% of your principal. The terms of the securities differ from those
of ordinary debt securities in that the securities do not pay interest and provide for the minimum return of only 10% of the principal
amount at maturity. At maturity, you will receive for each $1,000 stated principal amount of securities that you hold
an amount in cash based upon the final index value of each underlying index. If the final index value of either underlying
index is less than 90% of its respective initial index value, you will lose 1% of your principal for every 1% decline in the final
index value of the worst performing underlying index beyond the buffer amount of 10%. You could lose up to 90% of
the stated principal amount of the securities.
|
|
§
|
You are exposed to the price risk of both underlying
indices. Your return on the securities is not linked to a basket consisting of both underlying indices. Rather,
it will be based upon the independent performance of each underlying index. Unlike an instrument with a return linked
to a basket of underlying assets, in which risk is mitigated and diversified among all the components of the basket, you will be
exposed to the risks related to both underlying indices. Poor performance by either underlying index over the term of
the securities will negatively affect your return and will not be offset or mitigated by any positive performance by the other
underlying index. If the final index value of either underlying index declines to below 90% of its respective initial
index value, you will be exposed to the negative performance of the worst performing underlying index at maturity, even if the
other underlying index has appreciated or has not declined as much. Accordingly, your investment is subject to the price
risk of both underlying indices.
|
|
§
|
Because the securities are linked to the performance
of the worst performing underlying index, you are exposed to greater risk of sustaining a loss on your investment than if the securities
were linked to just one underlying index. The risk that you will suffer a loss on your investment is greater if
you invest in the securities as opposed to substantially similar securities that are linked to the performance of just one underlying
index. With two underlying indices, it is more likely that the final index value of either underlying index will decline
to below its respective downside threshold value than if the securities were linked to only one underlying index. Therefore,
it is more likely that you will suffer a loss on your investment.
|
|
§
|
Appreciation potential is fixed and limited. Where
the final index value of each underlying index is greater than or equal to its respective downside threshold value, the appreciation
potential of the securities is limited to the fixed upside payment of $105.00 per security (10.50% of the stated principal amount),
even if both underlying indices have appreciated substantially.
|
|
§
|
The amount payable on the securities is not linked
to the values of the underlying indices at any time other than the valuation date. The final index value of each underlying
index will be based on the index closing value of such underlying index on the valuation date, subject to postponement for non-index
business days and certain market disruption events. Even if the values of both underlying indices appreciate prior to the valuation
date but the value of either underlying index drops by the valuation date, the payment at maturity may be less, and may be significantly
less, than it would have been had the payment at maturity been linked to the values of the underlying indices prior to such drop.
Although the actual values of the underlying indices on the stated maturity date or at other times during the term of the securities
may be higher than their respective final index values, the payment at maturity will be based solely on the index closing values
on the valuation date.
|
|
§
|
The securities will not be listed on any securities
exchange and secondary trading may be limited. The securities will not be listed on any securities exchange. Therefore,
there may be little or no secondary market for the securities. Morgan Stanley & Co. LLC, which we refer to as MS
& Co., may, but is not obligated to, make a market in the securities and, if it once chooses to make a market, may cease doing
so at any time. When it does make a market, it will generally do so for transactions of routine secondary market size at prices
based on its estimate of the current value of the securities, taking into account its bid/offer spread, our credit spreads, market
volatility, the notional size of the proposed sale, the cost of unwinding any related hedging positions, the time
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
remaining to maturity and the likelihood that it will
be able to resell the securities. Even if there is a secondary market, it may not provide enough liquidity to allow
you to trade or sell the securities easily. Since other broker-dealers may not participate significantly in the secondary
market for the securities, the price at which you may be able to trade your securities is likely to depend on the price, if any,
at which MS & Co. is willing to transact. If, at any time, MS & Co. were to cease making a market in the securities,
it is likely that there would be no secondary market for the securities. Accordingly, you should be willing to hold
your securities to maturity.
|
§
|
The market price of the securities may be influenced
by many unpredictable factors. Several factors, many of which are beyond our control, will influence the value of
the securities in the secondary market and the price at which MS & Co. may be willing to purchase or sell the securities in
the secondary market, including:
|
|
§
|
the values of the underlying indices at any time (including
in relation to their initial index values),
|
|
§
|
the volatility (frequency and magnitude of changes
in value) of the underlying indices,
|
|
§
|
dividend rates on the securities underlying the underlying
indices,
|
|
§
|
interest and yield rates in the market,
|
|
§
|
geopolitical conditions and economic, financial, political,
regulatory or judicial events that affect the component stocks of the underlying indices or securities markets generally and which
may affect the value of the underlying indices,
|
|
§
|
the time remaining until the maturity of the securities,
|
|
§
|
the composition of the underlying indices and changes
in the constituent stocks of the underlying indices, and
|
|
§
|
any actual or anticipated changes in our credit ratings
or credit spreads.
|
Some or all of these factors will influence the price
you will receive if you sell your securities prior to maturity. In particular, you may have to sell your securities
at a substantial discount from the stated principal amount if at the time of sale the value of either underlying index is near,
at or below its respective downside threshold value.
You cannot predict the future performance of the underlying
indices based on their historical performance. If the final index value of either underlying index is less than 90%
of its respective initial index value, you will be exposed on a 1-to-1 basis to the decline in the final index value of the worst
performing underlying index beyond the buffer amount. There can be no assurance that the final index value of each underlying
index will be greater than or equal to 90% of its respective initial index value so that you will receive at maturity an amount
that is greater than the $1,000 stated principal amount for each security you hold, or that you will not lose some or a significant
portion of your investment.
|
§
|
The securities are subject to our credit risk,
and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the securities. You
are dependent on our ability to pay all amounts due on the securities at maturity and therefore you are subject to our credit risk. If
we default on our obligations under the securities, your investment would be at risk and you could lose some or all of your investment. As
a result, the market value of the securities prior to maturity will be affected by changes in the market’s view of our creditworthiness. Any
actual or anticipated decline in our credit ratings or increase in the credit spreads charged by the market for taking our credit
risk is likely to adversely affect the market value of the securities.
|
|
§
|
As a finance subsidiary, MSFL has no independent
operations and will have no independent assets. As a finance subsidiary, MSFL has no independent operations beyond
the issuance and administration of its securities and will have no independent assets available for distributions to holders of
MSFL securities if they make claims in respect of such securities in a bankruptcy, resolution or similar proceeding. Accordingly,
any recoveries by such holders will be limited to those available under the related guarantee by Morgan Stanley and that guarantee
will rank pari passu with all other unsecured, unsubordinated obligations of Morgan Stanley. Holders will have recourse
only to a single claim against Morgan Stanley and its assets under the guarantee. Holders of securities issued by MSFL should accordingly
assume that in any such proceedings they would not have any priority over and should be treated pari passu with the claims
of other unsecured, unsubordinated creditors of Morgan Stanley, including holders of Morgan Stanley-issued securities.
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
|
§
|
The rate we are willing to pay for securities of
this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous
to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the
securities in the original issue price reduce the economic terms of the securities, cause the estimated value of the securities
to be less than the original issue price and will adversely affect secondary market prices. Assuming no change in
market conditions or any other relevant factors, the prices, if any, at which dealers, including MS & Co., are willing to purchase
the securities in secondary market transactions will likely be significantly lower than the original issue price, because secondary
market prices will exclude the issuing, selling, structuring and hedging-related costs that are included in the original issue
price and borne by you and because the secondary market prices will reflect our secondary market credit spreads and the bid-offer
spread that any dealer would charge in a secondary market transaction of this type as well as other factors.
|
The inclusion of the costs of issuing, selling, structuring
and hedging the securities in the original issue price and the lower rate we are willing to pay as issuer make the economic terms
of the securities less favorable to you than they otherwise would be.
However, because the costs associated with issuing,
selling, structuring and hedging the securities are not fully deducted upon issuance, for a period of up to 6 months following
the issue date, to the extent that MS & Co. may buy or sell the securities in the secondary market, absent changes in market
conditions, including those related to the underlying indices, and to our secondary market credit spreads, it would do so based
on values higher than the estimated value, and we expect that those higher values will also be reflected in your brokerage account
statements.
|
§
|
The estimated value of the securities is determined
by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum
secondary market price. These pricing and valuation models are proprietary and rely in part on subjective views
of certain market inputs and certain assumptions about future events, which may prove to be incorrect. As a result,
because there is no market-standard way to value these types of securities, our models may yield a higher estimated value of the
securities than those generated by others, including other dealers in the market, if they attempted to value the securities. In
addition, the estimated value on the pricing date does not represent a minimum or maximum price at which dealers, including MS
& Co., would be willing to purchase your notes in the secondary market (if any exists) at any time. The value of your securities
at any time after the date of this document will vary based on many factors that cannot be predicted with accuracy, including our
creditworthiness and changes in market conditions. See also “The market price of the securities may be influenced
by many unpredictable factors” above.
|
|
§
|
Investing in the securities is not equivalent to
investing in the underlying indices. Investing in the securities is not equivalent to investing in either underlying
index or the component stocks of either underlying index. Investors in the securities will not have voting rights or
rights to receive dividends or other distributions or any other rights with respect to stocks that constitute the underlying indices.
|
|
§
|
Adjustments to the underlying indices could adversely
affect the value of the securities. The publisher of either underlying index may add, delete or substitute the stocks
underlying such index or make other methodological changes that could change the value of such underlying index. Any
of these actions could adversely affect the value of the securities. The publisher of such underlying index may also
discontinue or suspend calculation or publication of such underlying index at any time. In these circumstances, MS &
Co., as the calculation agent, will have the sole discretion to substitute a successor index that is comparable to the discontinued
underlying index. MS & Co. could have an economic interest that is different than that of investors in the securities
insofar as, for example, MS & Co. is permitted to consider indices that are calculated and published by MS & Co. or any
of its affiliates. If MS & Co. determines that there is no appropriate successor index, the payout on the securities
at maturity will be an amount based on the closing prices on the valuation date of the stocks underlying the relevant index at
the time of such discontinuance, without rebalancing or substitution, computed by the calculation agent in accordance with the
formula for calculating such underlying index last in effect prior to such discontinuance (depending also on the performance of
the other underlying index).
|
|
§
|
The calculation agent, which is a subsidiary of
Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the securities. As calculation
agent, MS & Co. will determine the initial index values, the downside threshold values, the final index values and the index
percent changes, if applicable, and
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
the payment that you will receive at maturity. Moreover,
certain determinations made by MS & Co., in its capacity as calculation agent, may require it to exercise discretion and make
subjective judgments, such as with respect to the occurrence or non-occurrence of market disruption events and the selection of
a successor index or calculation of the index closing values in the event of a market disruption event or discontinuance of an
underlying index. These potentially subjective determinations may adversely affect the payout to you at maturity. For
further information regarding these types of determinations, see “Description of Securities—Postponement of Valuation
Date(s),” “—Discontinuance of Any Underlying Index or Basket Index; Alteration of Method of Calculation,”
“—Alternate Exchange Calculation in case of an Event of Default” and “—Calculation Agent and Calculations”
in the accompanying product supplement. In addition, MS & Co. has determined the estimated value of the securities
on the pricing date.
|
§
|
Hedging and trading activity by our affiliates
could potentially adversely affect the value of the securities. One or more of our affiliates and/or third-party
dealers expect to carry out hedging activities related to the securities (and to other instruments linked to the underlying indices
or their component stocks), including trading in the stocks that constitute the underlying indices as well as in other instruments
related to the underlying indices. As a result, these entities may be unwinding or adjusting hedge positions during
the term of the securities, and the hedging strategy may involve greater and more frequent dynamic adjustments to the hedge as
the valuation date approaches. Some of our affiliates also trade the stocks that constitute the underlying indices and
other financial instruments related to the underlying indices on a regular basis as part of their general broker-dealer and other
businesses. Any of these hedging or trading activities on or prior to the pricing date could potentially increase the
initial index value of an underlying index, and, therefore, could increase the value at or above which such underlying index must
close on the valuation date so that you do not suffer a loss on your initial investment in the securities (depending also on the
performance of the other underlying index). Additionally, such hedging or trading activities during the term of the
securities, including on the valuation date, could adversely affect the value of either underlying index on the valuation date,
and, accordingly, the amount of cash an investor will receive at maturity (depending also on the performance of the other underlying
index).
|
|
§
|
The U.S. federal income tax consequences of an
investment in the securities are uncertain. Please read the discussion under “Additional Information—Tax considerations”
in this document and the discussion under “United States Federal Taxation” in the accompanying product supplement for
Jump Securities (together, the “Tax Disclosure Sections”) concerning the U.S. federal income tax consequences of an
investment in the securities. If the Internal Revenue Service (the “IRS”) were successful in asserting an
alternative treatment, the timing and character of income on the securities might differ significantly from the tax treatment described
in the Tax Disclosure Sections. For example, under one possible treatment, the IRS could seek to recharacterize the securities
as debt instruments. In that event, U.S. Holders would be required to accrue into income original issue discount on the securities
every year at a “comparable yield” determined at the time of issuance and recognize all income and gain in respect
of the securities as ordinary income. Additionally, as discussed under “United States Federal Taxation—FATCA”
in the accompanying product supplement for Jump Securities, the withholding rules commonly referred to as “FATCA” would
apply to the securities if they were recharacterized as debt instruments. However, recently proposed regulations (the
preamble to which specifies that taxpayers are permitted to rely on them pending finalization) eliminate the withholding requirement
on payments of gross proceeds of a taxable disposition (other than amounts treated as “FDAP income,” as defined in
the accompanying product supplement for Jump Securities). The risk that financial instruments providing for buffers,
triggers or similar downside protection features, such as the securities, would be recharacterized as debt is greater than the
risk of recharacterization for comparable financial instruments that do not have such features. We do not plan to request
a ruling from the IRS regarding the tax treatment of the securities, and the IRS or a court may not agree with the tax treatment
described in the Tax Disclosure Sections.
|
In 2007, the U.S. Treasury Department and the IRS
released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar
instruments. The notice focuses in particular on whether to require holders of these instruments to accrue income over
the term of their investment. It also asks for comments on a number of related topics, including the character of income
or loss with respect to these instruments; whether short-term instruments should be subject to any such accrual regime; the relevance
of factors such as the exchange-traded status of the instruments and the nature of the underlying property to which the instruments
are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject
to withholding tax; and whether these instruments are or should be subject to the
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
“constructive ownership” rule, which very
generally can operate to recharacterize certain long-term capital gain as ordinary income and impose an interest charge. While
the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated
after consideration of these issues could materially and adversely affect the tax consequences of an investment in the securities,
possibly with retroactive effect. Both U.S. and Non-U.S. Holders should consult their tax advisers regarding the U.S.
federal income tax consequences of an investment in the securities, including possible alternative treatments, the issues presented
by this notice and any tax consequences arising under the laws of any state, local or non-U.S. taxing jurisdiction.
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
S&P 500® Index Overview
The S&P 500® Index, which is calculated, maintained
and published by S&P Dow Jones Indices LLC (“S&P”), consists of stocks of 500 component companies selected
to provide a performance benchmark for the U.S. equity markets. The calculation of the S&P 500® Index
is based on the relative value of the float adjusted aggregate market capitalization of the 500 component companies as of a particular
time as compared to the aggregate average market capitalization of 500 similar companies during the base period of the years 1941
through 1943. For additional information about the S&P 500® Index, see the information set forth
under “S&P 500® Index” in the accompanying index supplement.
Information as of market close on June 30, 2020:
Bloomberg Ticker Symbol:
|
SPX
|
Current Index Value:
|
3,100.29
|
52 Weeks Ago:
|
2,964.33
|
52 Week High (on 2/19/2020):
|
3,386.15
|
52 Week Low (on 3/23/2020):
|
2,237.40
|
|
|
The following graph sets forth the daily closing values of the
SPX Index for the period from January 1, 2015 through June 30, 2020. The related table sets forth the published high
and low closing values, as well as end-of-quarter closing values, of the SPX Index for each quarter in the same period. The
closing value of the SPX Index on June 30, 2020 was 3,100.29. We obtained the information in the table and graph below
from Bloomberg Financial Markets, without independent verification. The SPX Index has at times experienced periods of
high volatility, and you should not take the historical values of the SPX Index as an indication of its future performance.
SPX Index Daily Closing Values
January 1, 2015 to June 30, 2020
|
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
S&P 500® Index
|
High
|
Low
|
Period End
|
2015
|
|
|
|
First Quarter
|
2,117.39
|
1,992.67
|
2,067.89
|
Second Quarter
|
2,130.82
|
2,057.64
|
2,063.11
|
Third Quarter
|
2,128.28
|
1,867.61
|
1,920.03
|
Fourth Quarter
|
2,109.79
|
1,923.82
|
2,043.94
|
2016
|
|
|
|
First Quarter
|
2,063.95
|
1,829.08
|
2,059.74
|
Second Quarter
|
2,119.12
|
2,000.54
|
2,098.86
|
Third Quarter
|
2,190.15
|
2,088.55
|
2,168.27
|
Fourth Quarter
|
2,271.72
|
2,085.18
|
2,238.83
|
2017
|
|
|
|
First Quarter
|
2,395.96
|
2,257.83
|
2,362.72
|
Second Quarter
|
2,453.46
|
2,328.95
|
2,423.41
|
Third Quarter
|
2,519.36
|
2,409.75
|
2,519.36
|
Fourth Quarter
|
2,690.16
|
2,529.12
|
2,673.61
|
2018
|
|
|
|
First Quarter
|
2,872.87
|
2,581.00
|
2,640.87
|
Second Quarter
|
2,786.85
|
2,581.88
|
2,718.37
|
Third Quarter
|
2,930.75
|
2,713.22
|
2,913.98
|
Fourth Quarter
|
2,925.51
|
2,351.10
|
2,506.85
|
2019
|
|
|
|
First Quarter
|
2,854.88
|
2,447.89
|
2,834.40
|
Second Quarter
|
2,954.18
|
2,744.45
|
2,941.76
|
Third Quarter
|
3,025.86
|
2,840.60
|
2,976.74
|
Fourth Quarter
|
3,240.02
|
2,887.61
|
3,230.78
|
2020
|
|
|
|
First Quarter
|
3,386.15
|
2,237.40
|
2,584.59
|
Second Quarter
|
3,232.39
|
2,470.50
|
3,100.29
|
|
|
|
|
“Standard & Poor’s®,” “S&P®,”
“S&P 500®,” “Standard & Poor’s 500” and “500” are trademarks of
Standard and Poor’s Financial Services LLC. For more information, see “S&P 500® Index”
in the accompanying index supplement.
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
NASDAQ-100 Index® Overview
The NASDAQ-100 Index®, which is calculated, maintained
and published by Nasdaq, Inc., is a modified capitalization-weighted index of 100 of the largest and most actively traded equity
securities of non-financial companies listed on The NASDAQ Stock Market LLC. The NASDAQ-100 Index® includes
companies across a variety of major industry groups. At any moment in time, the value of the NASDAQ-100 Index® equals
the aggregate value of the then-current NASDAQ-100 Index® share weights of each of the NASDAQ-100 Index® component
securities, which are based on the total shares outstanding of each such NASDAQ-100 Index® component security,
multiplied by each such security’s respective last sale price on NASDAQ (which may be the official closing price published
by NASDAQ), and divided by a scaling factor, which becomes the basis for the reported NASDAQ-100 Index® value. For
additional information about the NASDAQ-100 Index®, see the information set forth under “NASDAQ-100 Index®”
in the accompanying index supplement.
Information as of market close on June 30, 2020:
Bloomberg Ticker Symbol:
|
NDX
|
Current Index Value:
|
10,156.850
|
52 Weeks Ago:
|
7,768.138
|
52 Week High (on 6/23/2020):
|
10,209.820
|
52 Week Low (on 3/20/2020):
|
6,994.291
|
|
|
The following graph sets forth the daily closing values of the
NDX Index for the period from January 1, 2015 through June 30, 2020. The related table sets forth the published high
and low closing values, as well as end-of-quarter closing values, of the NDX Index for each quarter in the same period. The
closing value of the NDX Index on June 30, 2020 was 10,156.850. We obtained the information in the table below from
Bloomberg Financial Markets, without independent verification. The NDX Index has at times experienced periods of high
volatility, and you should not take the historical values of the NDX Index as an indication of its future performance.
NDX Index Daily Closing Values
January 1, 2015 to June 30, 2020
|
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
NASDAQ-100 Index®
|
High
|
Low
|
Period End
|
2015
|
|
|
|
First Quarter
|
4,483.049
|
4,089.648
|
4,333.688
|
Second Quarter
|
4,548.740
|
4,311.257
|
4,396.761
|
Third Quarter
|
4,679.675
|
4,016.324
|
4,181.060
|
Fourth Quarter
|
4,719.053
|
4,192.963
|
4,593.271
|
2016
|
|
|
|
First Quarter
|
4,497.857
|
3,947.804
|
4,483.655
|
Second Quarter
|
4,565.421
|
4,201.055
|
4,417.699
|
Third Quarter
|
4,891.363
|
4,410.747
|
4,875.697
|
Fourth Quarter
|
4,965.808
|
4,660.457
|
4,863.620
|
2017
|
|
|
|
First Quarter
|
5,439.742
|
4,911.333
|
5,436.232
|
Second Quarter
|
5,885.296
|
5,353.586
|
5,646.917
|
Third Quarter
|
6,004.380
|
5,596.956
|
5,979.298
|
Fourth Quarter
|
6,513.269
|
5,981.918
|
6,396.422
|
2018
|
|
|
|
First Quarter
|
7,131.121
|
6,306.100
|
6,581.126
|
Second Quarter
|
7,280.705
|
6,390.837
|
7,040.802
|
Third Quarter
|
7,660.180
|
7,014.554
|
7,627.650
|
Fourth Quarter
|
7,645.453
|
5,899.354
|
6,329.964
|
2019
|
|
|
|
First Quarter
|
7,493.270
|
6,147.128
|
7,378.771
|
Second Quarter
|
7,845.729
|
6,978.018
|
7,671.075
|
Third Quarter
|
8,016.953
|
7,415.691
|
7,749.449
|
Fourth Quarter
|
8,778.313
|
7,550.786
|
8,733.073
|
2020
|
|
|
|
First Quarter
|
9,718.727
|
6,994.291
|
7,813.499
|
Second Quarter
|
10,209.820
|
7,486.287
|
10,156.850
|
|
|
|
|
“Nasdaq®,” “NASDAQ-100®”
and “NASDAQ-100 Index®” are trademarks of Nasdaq, Inc. See “NASDAQ-100 Index®”
in the accompanying index supplement.
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
Additional Terms of the Securities
Please read this information in conjunction with the summary
terms on the front cover of this document.
If the terms described herein are inconsistent with those described in the accompanying product supplement, index supplement or prospectus, the terms described herein shall control.
|
Denominations:
|
$1,000 and integral multiples thereof
|
Underlying index publisher:
|
With respect to the SPX Index, S&P Dow Jones Indices LLC,
or any successor thereof.
With respect to the NDX Index, Nasdaq, Inc., or any successor
thereof.
|
Postponement of maturity date:
|
If the scheduled valuation date is not an index business day with respect to either underlying index or if a market disruption event occurs with respect to either underlying index on that day so that the valuation date is postponed and falls less than two business days prior to the scheduled maturity date, the maturity date of the securities will be postponed to the second business day following that valuation date as postponed with respect to either underlying index.
|
Trustee:
|
The Bank of New York Mellon
|
Calculation agent:
|
Morgan Stanley & Co. LLC (“MS & Co.”)
|
Issuer notice to registered security holders, the trustee and the depositary:
|
In the event that the maturity date is postponed due to postponement
of the valuation date, the issuer shall give notice of such postponement and, once it has been determined, of the date to which
the maturity date has been rescheduled (i) to each registered holder of the securities by mailing notice of such postponement by
first class mail, postage prepaid, to such registered holder’s last address as it shall appear upon the registry books, (ii)
to the trustee by facsimile confirmed by mailing such notice to the trustee by first class mail, postage prepaid, at its New York
office and (iii) to The Depository Trust Company (the “depositary”) by telephone or facsimile, confirmed by mailing
such notice to the depositary by first class mail, postage prepaid. Any notice that is mailed to a registered holder of the securities
in the manner herein provided shall be conclusively presumed to have been duly given to such registered holder, whether or not
such registered holder receives the notice. The issuer shall give such notice as promptly as possible, and in no case later than
(i) with respect to notice of postponement of the maturity date, the business day immediately preceding the scheduled maturity
date and (ii) with respect to notice of the date to which the maturity date has been rescheduled, the business day immediately
following the actual valuation date.
The issuer shall, or shall cause the calculation agent to, (i)
provide written notice to the trustee and to the depositary of the amount of cash to be delivered with respect to each stated principal
amount of the securities, on or prior to 10:30 a.m. (New York City time) on the business day preceding the maturity date, and (ii)
deliver the aggregate cash amount due with respect to the securities to the trustee for delivery to the depositary, as holder of
the securities, on the maturity date.
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
Additional Information About the Securities
Minimum ticketing size:
|
$1,000 / 1 security
|
Tax considerations:
|
Although there is uncertainty regarding the U.S. federal income
tax consequences of an investment in the securities due to the lack of governing authority, in the opinion of our counsel, Davis
Polk & Wardwell LLP, under current law, and based on current market conditions, a security should be treated as a single financial
contract that is an “open transaction” for U.S. federal income tax purposes.
Assuming this treatment of the securities is respected and subject
to the discussion in “United States Federal Taxation” in the accompanying product supplement for Jump Securities, the
following U.S. federal income tax consequences should result based on current law:
§
A U.S. Holder should not be required to recognize taxable
income over the term of the securities prior to settlement, other than pursuant to a sale or exchange.
§
Upon sale, exchange or settlement
of the securities, a U.S. Holder should recognize gain or loss equal to the difference between the amount realized and the U.S.
Holder’s tax basis in the securities. Such gain or loss should be long-term capital gain or loss if the investor
has held the securities for more than one year, and short-term capital gain or loss otherwise.
In 2007, the U.S. Treasury Department and the Internal Revenue
Service (the “IRS”) released a notice requesting comments on the U.S. federal income tax treatment of “prepaid
forward contracts” and similar instruments. The notice focuses in particular on whether to require holders of
these instruments to accrue income over the term of their investment. It also asks for comments on a number of related
topics, including the character of income or loss with respect to these instruments; whether short-term instruments should be subject
to any such accrual regime; the relevance of factors such as the exchange-traded status of the instruments and the nature of the
underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals)
realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to
the “constructive ownership” rule, which very generally can operate to recharacterize certain long-term capital gain
as ordinary income and impose an interest charge. While the notice requests comments on appropriate transition rules
and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially
and adversely affect the tax consequences of an investment in the securities, possibly with retroactive effect.
As discussed in the accompanying product supplement for Jump
Securities, Section 871(m) of the Internal Revenue Code of 1986, as amended, and Treasury regulations promulgated thereunder (“Section
871(m)”) generally impose a 30% (or a lower applicable treaty rate) withholding tax on dividend equivalents paid or deemed
paid to Non-U.S. Holders with respect to certain financial instruments linked to U.S. equities or indices that include U.S. equities
(each, an “Underlying Security”). Subject to certain exceptions, Section 871(m) generally applies to securities
that substantially replicate the economic performance of one or more Underlying Securities, as determined based on tests set forth
in the applicable Treasury regulations (a “Specified Security”). However, pursuant to an IRS notice, Section
871(m) will not apply to securities issued before January 1, 2023 that do not have a delta of one with respect to any Underlying
Security. Based on our determination that the securities do not have a delta of one with respect to any Underlying Security,
our counsel is of the opinion that the securities should not be Specified Securities and, therefore, should not be subject to Section
871(m).
Our determination is not binding on the IRS, and the IRS may
disagree with this determination. Section 871(m) is complex and its application may depend on your particular circumstances,
including whether you enter into other transactions with respect to an Underlying Security. If withholding is required,
we will not be required to pay any additional amounts with respect to the amounts so withheld. You should consult your
tax adviser regarding the potential application of Section 871(m) to the securities.
Both U.S. and non-U.S. investors considering an investment
in the securities should read the discussion under “Risk Factors” in this document and the discussion under “United
States Federal Taxation” in the accompanying product supplement for Jump Securities and consult their tax advisers regarding
all aspects of the U.S. federal income tax consequences of an investment in the securities, including possible alternative treatments,
the issues presented by the aforementioned notice and any tax consequences arising under the laws of any state, local or non-U.S.
taxing jurisdiction.
The discussion in the preceding paragraphs under “Tax
considerations” and the discussion contained in the section entitled “United States Federal Taxation” in the
accompanying product
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
|
supplement for Jump Securities, insofar as they purport to describe provisions of U.S. federal income tax laws or legal conclusions with respect thereto, constitute the full opinion of Davis Polk & Wardwell LLP regarding the material U.S. federal tax consequences of an investment in the securities.
|
Use of proceeds and hedging:
|
The proceeds from the sale of the securities will be used by
us for general corporate purposes. We will receive, in aggregate, $1,000 per security issued, because, when we enter into hedging
transactions in order to meet our obligations under the securities, our hedging counterparty will reimburse the cost of the agent’s
commissions. The costs of the securities borne by you and described beginning on page 2 above comprise the agent’s commissions
and the cost of issuing, structuring and hedging the securities.
On or prior to the pricing date, we expect to hedge our anticipated
exposure in connection with the securities by entering into hedging transactions with our affiliates and/or third-party dealers. We
expect our hedging counterparties to take positions in stocks of the underlying indices and in futures and options contracts on
the underlying indices and any component stocks of the underlying indices listed on major securities markets. Such purchase
activity could potentially increase the initial index value of either underlying index, and, therefore, could increase the value
at or above which such underlying index must close on the valuation date so that you do not suffer a loss on your initial investment
in the securities (depending also on the performance of the other underlying index). In addition, through our affiliates,
we are likely to modify our hedge position throughout the term of the securities, including on the valuation date, by purchasing
and selling the stocks constituting the underlying indices, futures or options contracts on the underlying indices or their component
stocks listed on major securities markets or positions in any other available securities or instruments that we may wish to use
in connection with such hedging activities. As a result, these entities may be unwinding or adjusting hedge positions
during the term of the securities, and the hedging strategy may involve greater and more frequent dynamic adjustments to the hedge
as the valuation date approaches. We cannot give any assurance that our hedging activities will not affect the value
of either underlying index, and, therefore, adversely affect the value of the securities or the payment you will receive at maturity
(depending also on the performance of the other underlying index). For further information on our use of proceeds and
hedging, see “Use of Proceeds and Hedging” in the accompanying product supplement.
|
Benefit plan investor considerations:
|
Each fiduciary of a pension, profit-sharing or other employee
benefit plan subject to Title I of the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) (a “Plan”),
should consider the fiduciary standards of ERISA in the context of the Plan’s particular circumstances before authorizing
an investment in the securities. Accordingly, among other factors, the fiduciary should consider whether the investment
would satisfy the prudence and diversification requirements of ERISA and would be consistent with the documents and instruments
governing the Plan.
In addition, we and certain of our affiliates, including MS &
Co., may each be considered a “party in interest” within the meaning of ERISA, or a “disqualified person”
within the meaning of the Internal Revenue Code of 1986, as amended (the “Code”), with respect to many Plans, as well
as many individual retirement accounts and Keogh plans (such accounts and plans, together with other plans, accounts and arrangements
subject to Section 4975 of the Code, also “Plans”). ERISA Section 406 and Code Section 4975 generally prohibit
transactions between Plans and parties in interest or disqualified persons. Prohibited transactions within the meaning
of ERISA or the Code would likely arise, for example, if the securities are acquired by or with the assets of a Plan with respect
to which MS & Co. or any of its affiliates is a service provider or other party in interest, unless the securities are acquired
pursuant to an exemption from the “prohibited transaction” rules. A violation of these “prohibited
transaction” rules could result in an excise tax or other liabilities under ERISA and/or Section 4975 of the Code for those
persons, unless exemptive relief is available under an applicable statutory or administrative exemption.
The U.S. Department of Labor has issued five prohibited transaction
class exemptions (“PTCEs”) that may provide exemptive relief for direct or indirect prohibited transactions resulting
from the purchase or holding of the securities. Those class exemptions are PTCE 96-23 (for certain transactions determined
by in-house asset managers), PTCE 95-60 (for certain transactions involving insurance company general accounts), PTCE 91-38 (for
certain transactions involving bank collective investment funds), PTCE 90-1 (for certain transactions involving insurance company
separate accounts) and PTCE 84-14 (for certain transactions determined by independent qualified professional asset managers). In
addition, ERISA Section 408(b)(17) and Code Section 4975(d)(20) of the Code provide an exemption for the purchase and sale of securities
and the related lending transactions, provided that neither the issuer of the securities nor any of its affiliates has or exercises
any discretionary authority or control or renders any investment advice with respect to the assets of the Plan involved in the
transaction and provided further that the Plan pays no more, and receives no less, than “adequate consideration” in
connection with the transaction (the so-called “service provider” exemption). There can be no assurance
that any of these class or statutory exemptions will be available with respect to transactions involving the securities.
Because we may be considered a party in interest with respect
to many Plans, the securities may not be purchased, held or disposed of by any Plan, any entity whose underlying assets include
“plan assets” by reason of any Plan’s investment in the entity (a “Plan Asset Entity”) or any person
investing “plan assets” of any Plan, unless such purchase, holding or disposition is eligible for exemptive relief,
including relief
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
|
available under PTCEs 96-23, 95-60, 91-38, 90-1, 84-14 or the
service provider exemption or such purchase, holding or disposition is otherwise not prohibited. Any purchaser, including
any fiduciary purchasing on behalf of a Plan, transferee or holder of the securities will be deemed to have represented, in its
corporate and its fiduciary capacity, by its purchase and holding of the securities that either (a) it is not a Plan or a Plan
Asset Entity and is not purchasing such securities on behalf of or with “plan assets” of any Plan or with any assets
of a governmental, non-U.S. or church plan that is subject to any federal, state, local or non-U.S. law that is substantially similar
to the provisions of Section 406 of ERISA or Section 4975 of the Code (“Similar Law”) or (b) its purchase, holding
and disposition of these securities will not constitute or result in a non-exempt prohibited transaction under Section 406 of ERISA
or Section 4975 of the Code or violate any Similar Law.
Due to the complexity of these rules and the penalties that may
be imposed upon persons involved in non-exempt prohibited transactions, it is particularly important that fiduciaries or other
persons considering purchasing the securities on behalf of or with “plan assets” of any Plan consult with their counsel
regarding the availability of exemptive relief.
The securities are contractual financial instruments. The
financial exposure provided by the securities is not a substitute or proxy for, and is not intended as a substitute or proxy for,
individualized investment management or advice for the benefit of any purchaser or holder of the securities. The securities
have not been designed and will not be administered in a manner intended to reflect the individualized needs and objectives of
any purchaser or holder of the securities.
Each purchaser or holder of any securities acknowledges and agrees
that:
(i)
the purchaser or holder or its fiduciary has made and
shall make all investment decisions for the purchaser or holder and the purchaser or holder has not relied and shall not rely in
any way upon us or our affiliates to act as a fiduciary or adviser of the purchaser or holder with respect to (A) the design and
terms of the securities, (B) the purchaser or holder’s investment in the securities, or (C) the exercise of or failure to
exercise any rights we have under or with respect to the securities;
(ii)
we and our affiliates have acted
and will act solely for our own account in connection with (A) all transactions relating to the securities and (B) all hedging
transactions in connection with our obligations under the securities;
(iii)
any and all assets and positions
relating to hedging transactions by us or our affiliates are assets and positions of those entities and are not assets and positions
held for the benefit of the purchaser or holder;
(iv)
our interests are adverse to
the interests of the purchaser or holder; and
(v)
neither we nor any of our affiliates
is a fiduciary or adviser of the purchaser or holder in connection with any such assets, positions or transactions, and any information
that we or any of our affiliates may provide is not intended to be impartial investment advice.
Each purchaser and holder of the securities has exclusive responsibility
for ensuring that its purchase, holding and disposition of the securities do not violate the prohibited transaction rules of ERISA
or the Code or any Similar Law. The sale of any securities to any Plan or plan subject to Similar Law is in no respect
a representation by us or any of our affiliates or representatives that such an investment meets all relevant legal requirements
with respect to investments by plans generally or any particular plan, or that such an investment is appropriate for plans generally
or any particular plan. In this regard, neither this discussion nor anything provided in this document is or is intended to be
investment advice directed at any potential Plan purchaser or at Plan purchasers generally and such purchasers of these securities
should consult and rely on their own counsel and advisers as to whether an investment in these securities is suitable.
However, individual retirement accounts, individual retirement
annuities and Keogh plans, as well as employee benefit plans that permit participants to direct the investment of their accounts,
will not be permitted to purchase or hold the securities if the account, plan or annuity is for the benefit of an employee of Morgan
Stanley, Morgan Stanley Wealth Management or a family member and the employee receives any compensation (such as, for example,
an addition to bonus) based on the purchase of the securities by the account, plan or annuity.
|
Additional considerations:
|
Client accounts over which Morgan Stanley, Morgan Stanley Wealth Management or any of their respective subsidiaries have investment discretion are not permitted to purchase the securities, either directly or indirectly.
|
Supplemental information regarding plan of distribution; conflicts of interest:
|
MS & Co. expects to sell all of the securities that it purchases
from us to an unaffiliated dealer at a price of $1,000 per security, for further sale to certain fee-based advisory accounts at
the price to public of $1,000 per security. MS & Co. will not receive a sales commission with respect to the securities.
|
Morgan Stanley Finance LLC
|
Enhanced Buffered Jump Securities Based on the Value of the Worst Performing of the S&P 500® Index and the NASDAQ-100 Index® due October 5, 2021
Principal at Risk Securities
|
|
MS & Co. is an affiliate of MSFL and a wholly owned subsidiary
of Morgan Stanley, and it and other affiliates of ours expect to make a profit by selling, structuring and, when applicable, hedging
the securities.
MS & Co. will conduct this offering in compliance with the
requirements of FINRA Rule 5121 of the Financial Industry Regulatory Authority, Inc., which is commonly referred to as FINRA, regarding
a FINRA member firm’s distribution of the securities of an affiliate and related conflicts of interest. MS &
Co. or any of our other affiliates may not make sales in this offering to any discretionary account. See “Plan of Distribution
(Conflicts of Interest)” and “Use of Proceeds and Hedging” in the accompanying product supplement.
|
Validity of the securities:
|
In the opinion of Davis Polk & Wardwell LLP, as special counsel to MSFL and Morgan Stanley, when the securities offered by this pricing supplement have been executed and issued by MSFL, authenticated by the trustee pursuant to the MSFL Senior Debt Indenture (as defined in the accompanying prospectus) and delivered against payment as contemplated herein, such securities will be valid and binding obligations of MSFL and the related guarantee will be a valid and binding obligation of Morgan Stanley, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to (i) the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above and (ii) any provision of the MSFL Senior Debt Indenture that purports to avoid the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law by limiting the amount of Morgan Stanley’s obligation under the related guarantee. This opinion is given as of the date hereof and is limited to the laws of the State of New York, the General Corporation Law of the State of Delaware and the Delaware Limited Liability Company Act. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the MSFL Senior Debt Indenture and its authentication of the securities and the validity, binding nature and enforceability of the MSFL Senior Debt Indenture with respect to the trustee, all as stated in the letter of such counsel dated November 16, 2017, which is Exhibit 5-a to the Registration Statement on Form S-3 filed by Morgan Stanley on November 16, 2017.
|
Where you can find more information:
|
Morgan Stanley and MSFL have filed a registration statement (including
a prospectus, as supplemented by the product supplement for Jump and the index supplement) with the Securities and Exchange Commission,
or SEC, for the offering to which this communication relates. You should read the prospectus in that registration statement,
the product supplement for Jump, the index supplement and any other documents relating to this offering that Morgan Stanley and
MSFL have filed with the SEC for more complete information about Morgan Stanley, MSFL and this offering. You may get
these documents without cost by visiting EDGAR on the SEC web site at.www.sec.gov. Alternatively,
Morgan Stanley, any underwriter or any dealer participating in the offering will arrange to send you the prospectus, the product
supplement for Jump and the index supplement if you so request by calling toll-free 800-584-6837.
You may access these documents on the SEC web site at.www.sec.gov
as follows:
Product Supplement for Jump Securities dated November 16, 2017
Index
Supplement dated November 16, 2017
Prospectus
dated November 16, 2017
Terms used but not defined in this document are defined in the
product supplement for Jump, in the index supplement or in the prospectus.
|
Morgan Stanley (NYSE:MS)
Historical Stock Chart
From Apr 2024 to May 2024
Morgan Stanley (NYSE:MS)
Historical Stock Chart
From May 2023 to May 2024